Atlas Trials

DM1

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch DM1

RecordFirmDate
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension (NCT07700225)Virginia Commonwealth University2026-08-01
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 (NCT07486934)Dyne Therapeutics2026-05-14
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 (NCT07008469)Avidity Biosciences, Inc.2025-06-26
The Spanish National Registry for Myotonic Dystrophy Type 1 (NCT07385443)Fundació Institut Germans Trias i Pujol2025-06-02
Global Study of Del-desiran for the Treatment of DM1 (NCT06411288)Avidity Biosciences, Inc.2024-05-30
Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients (NCT05479981)Avidity Biosciences, Inc.2022-08-04
Remote Assessments and Genetic Determinants of Myotonic Dystrophy (NCT07505342)University of Rochester2022-05-10
Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (NCT05027269)Avidity Biosciences, Inc.2021-10-28
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) (NCT03981575)Virginia Commonwealth University2019-01-01
Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients (NCT02084407)Institut de Myologie, France2013-11-01

Track DM1 automatically

Every clearance here is in the API, with alerts when new ones post.